Caisse DE Depot ET Placement DU Quebec cut its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 0.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,129,741 shares of the company's stock after selling 10,016 shares during the quarter. Caisse DE Depot ET Placement DU Quebec owned 0.56% of Docusign worth $91,961,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently made changes to their positions in the company. American Century Companies Inc. raised its position in shares of Docusign by 3.1% during the 1st quarter. American Century Companies Inc. now owns 5,477,758 shares of the company's stock valued at $445,890,000 after buying an additional 162,299 shares in the last quarter. Jericho Capital Asset Management L.P. raised its position in shares of Docusign by 34.0% during the 4th quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock valued at $427,642,000 after buying an additional 1,205,500 shares in the last quarter. Northern Trust Corp raised its position in shares of Docusign by 77.2% during the 4th quarter. Northern Trust Corp now owns 1,984,378 shares of the company's stock valued at $178,475,000 after buying an additional 864,408 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Docusign by 372.5% during the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after buying an additional 1,440,269 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Docusign by 3.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,709,807 shares of the company's stock valued at $153,780,000 after buying an additional 50,440 shares in the last quarter. Institutional investors own 77.64% of the company's stock.
Docusign Stock Up 1.5%
Shares of Docusign stock traded up $1.15 on Friday, reaching $76.66. The company's stock had a trading volume of 2,272,539 shares, compared to its average volume of 2,568,107. Docusign Inc. has a 52 week low of $54.31 and a 52 week high of $107.86. The firm's fifty day simple moving average is $75.41 and its two-hundred day simple moving average is $79.79. The company has a market capitalization of $15.49 billion, a price-to-earnings ratio of 14.49, a P/E/G ratio of 27.87 and a beta of 1.01.
Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, June 5th. The company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.81 by $0.09. Docusign had a return on equity of 14.27% and a net margin of 36.50%.The company had revenue of $763.65 million during the quarter, compared to the consensus estimate of $748.79 million. During the same period last year, the company earned $0.82 EPS. Docusign's revenue for the quarter was up 7.6% on a year-over-year basis. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, research analysts predict that Docusign Inc. will post 1.17 EPS for the current year.
Docusign declared that its board has approved a share buyback program on Thursday, June 5th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.6% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its shares are undervalued.
Insider Transactions at Docusign
In other news, CEO Allan C. Thygesen sold 40,000 shares of Docusign stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the transaction, the chief executive officer directly owned 143,983 shares of the company's stock, valued at $11,160,122.33. The trade was a 21.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Robert Chatwani sold 22,875 shares of Docusign stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25. Following the transaction, the insider directly owned 72,126 shares in the company, valued at approximately $5,394,303.54. The trade was a 24.08% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 78,552 shares of company stock valued at $5,983,631. 1.01% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
DOCU has been the topic of a number of recent research reports. Wells Fargo & Company upgraded shares of Docusign from an "underweight" rating to an "equal weight" rating and increased their price target for the company from $67.00 to $80.00 in a research report on Friday, June 13th. Wall Street Zen cut shares of Docusign from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. JMP Securities reiterated a "market outperform" rating and set a $124.00 price target on shares of Docusign in a research report on Tuesday, June 3rd. UBS Group reduced their price target on shares of Docusign from $85.00 to $80.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Finally, Robert W. Baird reduced their price target on shares of Docusign from $93.00 to $85.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Four investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. According to data from MarketBeat, Docusign has an average rating of "Hold" and a consensus target price of $89.77.
Read Our Latest Report on DOCU
Docusign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report